The professionals in our chemical and pharmaceutical patents group are educated and experienced in chemistry, including within biochemistry, organic chemistry, inorganic chemistry, analytical chemistry, and physical chemistry.

NK Patent Law has the knowledge and experience necessary to navigate the requirements of the U.S. Patent and Trademark Office (PTO) for filing and prosecuting chemical patents. Our work in this area includes fluorescent microscopy, electron microscopy, including sample holders having improved chemical traits, and chemical processes for making silicon chips, nanostars, and the like.

Ashley Johnson worked in biochemical research in both the pharmaceutical industry and at the University of North Carolina at Chapel Hill and brings over a decade of patent experience to the profession.

Dr. Laura Kiefer holds a PhD from Duke University in Biochemistry. Dr. Kiefer previously worked in-house and managed the entire patent portfolio for Affinergy, LLC, a leader in peptide chemistry and diagnostic products.

Joseph Shin has an extensive and wide range of technical knowledge, from pharmaceutical compounds to bio-molecules.

Ani Agrawal‘s chemistry background includes his research in cryogenics research and 6 years of teaching university chemistry.

 

 

Representative Work

U.S. Patent No. 8,859,223
“Compositions and methods for imaging beta-secretase activity in living cells and organisms”
Molecular probes are provided for use in fluorescence microscopy procedures for monitoring beta-secretase enzyme (BACE) activity in living cells and organisms. The probes may be useful for monitoring Alzheimer’s Disease-associated BACE in living cells. By fluorescing when hydrolyzed by BACE, the probes can allow for real-time spatial and temporal assessment of enzymatic activity without the need for mutated cell lines or antibodies. The molecular probes may also be used to screen libraries of potential BACE inhibitors or evaluate how external stimuli affect BACE activity.

U.S. Patent No. 8,067,021
“Methods and compositions for delivery of growth factor to fibrous connective tissue”
The presently disclosed subject matter relates to a peptide composition for non-covalently localizing fibrous connective tissue-inducing growth factor to a surface of an implant, the composition comprising a peptide having binding affinity for a surface material of an implant coupled to a peptide having binding affinity for a fibrous connective tissue-inducing growth factor. Methods are provided for delivering fibrous connective tissue-inducing growth factor GDF-7 in an amount effective to promote fibrous connective tissue repair and fibrous connective tissue formation. Also provided are methods of applying the peptide composition to an implant by contacting the composition with a surface of the implant; and kits comprising the compositions.

U.S. Patent No. 7,968,677
“IFBM’s to promote the specific attachment of target analytes to the surface of orthopedic implants”
Molecular probes are provided for use in fluorescence microscopy procedures for monitoring beta-secretase enzyme (BACE) activity in living cells and organisms. The probes may be useful for monitoring Alzheimer’s Disease-associated BACE in living cells. By fluorescing when hydrolyzed by BACE, the probes can allow for real-time spatial and temporal assessment of enzymatic activity without the need for mutated cell lines or antibodies. The molecular probes may also be used to screen libraries of potential BACE inhibitors or evaluate how external stimuli affect BACE activity.